Valeo Pharma (TSE:VPH) Hits New 1-Year Low at $0.06

Valeo Pharma Inc. (TSE:VPH) hit a new 52-week low during trading on Tuesday . The stock traded as low as C$0.06 and last traded at C$0.06, with a volume of 120873 shares trading hands. The stock had previously closed at C$0.07.

Valeo Pharma Stock Down 7.7 %

The business’s fifty day moving average is C$0.09 and its 200 day moving average is C$0.12. The stock has a market cap of C$5.92 million, a PE ratio of -0.18 and a beta of 2.39.

Valeo Pharma (TSE:VPH) last released its quarterly earnings data on Thursday, June 13th. The company reported C($0.08) earnings per share for the quarter, missing the consensus estimate of C($0.05) by C($0.03). The company had revenue of C$14.13 million during the quarter, compared to analysts’ expectations of C$15.50 million.

About Valeo Pharma

Valeo Pharma Inc, a specialty pharmaceutical company, engages in the acquisition, in-licensing brands, and sale of pharmaceuticals and hospital specialty products for unmet medical needs in Canada. Its product portfolio includes Enerzair Breezhaler, a LABA/LAMA/ICS fixed triple dose asthma drug; Atectura Breezhaler, a LABA/ICS dual combination asthma drug; Redesca, to treat and prevent deep vein thrombosis and pulmonary embolism; Onstryv, for the treatment of Idiopathic Parkinson's disease; M-Eslon, extended-release morphine sulphate used for pain management; and Yondelis, a soft tissue sarcoma.